Quality of Surgery and Outcome in Gastrointestinal Stromal Tumors Treated Within a Randomized Clinical Trial
This cohort substudy of a randomized clinical trial assesses the risk of death for patients with gastrointestinal stromal tumors with and without imatinib according to resection margin level using data from a randomized study on adjuvant imatinib.
Source: JAMA Surgery - Category: Sports Medicine Source Type: research
More News: Clinical Trials | Gastroenterology | Gastrointestinal Stromal Tumor (GIST) | Gleevec | Sports Medicine | Study